MedPath

A Study of side effects and quality of life in patients with oral cavity and oropharyngeal cancers undergoing radiotherapy.

Not Applicable
Conditions
Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Registration Number
CTRI/2024/08/072273
Lead Sponsor
Sri Venkateswara Institute of Medical Sciences Tirupati
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Carcinoma of head and neck including oral cavity, oropharynx undergoing IMRT, VMAT and concurrent chemotherapy .

2.Patients of age group between 18-65 yrs.

3.Patient with ECOG 0-2.

4.Patients willing to sign an informed consent

Exclusion Criteria

1. Patients with previous history of radiation to head and neck.

2. Patients with known distant metastasis.

3. Patients with ECOG 3-4

4. Pregnant women and lactating mothers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the toxicities in patients of head and neck cancer undergoing radiotherapy <br/ ><br>1) pain, <br/ ><br>2) oral mucositis <br/ ><br>3) XerostomiaTimepoint: From Day 1 of treatment to 6 months after treatment completion.
Secondary Outcome Measures
NameTimeMethod
To assess the quality of lifeTimepoint: From Day 1 of treatment to 6 months after treatment completion.
© Copyright 2025. All Rights Reserved by MedPath